Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UroGen Pharma (URGN) Shares Outstanding (Diluted Average): 2016-2017

Historic Shares Outstanding (Diluted Average) for UroGen Pharma (URGN) over the last 2 years, with Dec 2017 value amounting to $13.6 million.

  • UroGen Pharma's Shares Outstanding (Diluted Average) rose 64.12% to $13.6 million in Q4 2017 from the same period last year, while for Dec 2017 it was $13.6 million, marking a year-over-year increase of 64.12%. This contributed to the annual value of $13.6 million for FY2017, which is 64.12% up from last year.
  • Latest data reveals that UroGen Pharma reported Shares Outstanding (Diluted Average) of $13.6 million as of FY2017, which was up 64.12% from $8.3 million recorded in FY2016.
  • In the past 5 years, UroGen Pharma's Shares Outstanding (Diluted Average) ranged from a high of $13.6 million in FY2017 and a low of $8.3 million during FY2016.
  • Over the past 2 years, UroGen Pharma's median Shares Outstanding (Diluted Average) value was $11.0 million (recorded in 2016), while the average stood at $11.0 million.
  • Data for UroGen Pharma's Shares Outstanding (Diluted Average) shows a peak YoY spiked of 64.12% (in 2017) over the last 5 years.
  • UroGen Pharma's Shares Outstanding (Diluted Average) (Yearly) stood at $8.3 million in 2016, then skyrocketed by 64.12% to $13.6 million in 2017.